Jason H Karlawish MD
Professor of Medicine, Medical Ethics and Health Policy, and Neurology at the University of Pennsylvania Perelman School of Medicine Director of the Penn Neurodegenerative Disease Ethics and Policy Program Associate Director of the Clinical Core and Co-Associate Director of the Alzheimer’s Disease Core Center Co-Director of the Penn Memory Center Director of Alzheimer’s Disease Core
Join to View Full Profile
3615 Chestnut StRalston Penn CenterPhiladelphia, PA 19104
Phone+1 215-662-2746
Dr. Karlawish is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Geriatric Medicine (Internal Medicine), 1995 - 1997
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1991 - 1994
Northwestern University The Feinberg School of MedicineClass of 1991
Certifications & Licensure
PA State Medical License 1997 - 2026
IL State Medical License 1994 - 1999
MD State Medical License 1993 - 1994
American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Memory Aid for Informed Consent in Alzheimer's Research Start of enrollment: 2004 Sep 01
- Encouraging Walking in Older Adults Start of enrollment: 2011 Mar 01
- Social Goals and Individual Incentives to Promote Walking in Older Adults Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Ethics from the Outset: Incorporating Ethical Considerations into the AI Tech Collaboratories' Pilot Projects.Emily A Largent, Yungjee Kim, Jason Karlawish, Anna Wexler
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2025-03-28 - Experiences of inner strength in persons newly diagnosed with mild cognitive impairment: A qualitative study.Brianna Morgan, Lauren Massimo, Sharon Ravitch, Abraham A Brody, Joshua Chodosh
Geriatric Nursing. 2025-02-05 - Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial.Joshua D Grill, Rema Raman, Charlene Flournoy, Karin Ernstrom, Aimee Pierce
Alzheimer's & Dementia. 2025-02-01
Journal Articles
- Desktop Medicine and the Practice of Wealth CareJason Karlawish, MD, JAMA Internal Medicine
- Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentJeffrey M Burns, Keith A Johnson, Reisa A Sperling, Jason Karlawish, JAMA Neurology
- Study Partners Should Be Required in Preclinical Alzheimer’s Disease TrialsJoshua D Grill, Jason Karlawish, BioMed Central
Authored Content
- The FDA Needs a Risk Evaluation and Mitigation Strategy for Alzheimer’s Drug LecanemabJune 2023
- How Can the Latest Alzheimer’s Therapy Reach Patients? Follow This Trustworthy ProcessOctober 2022
- We Can’t Drug Our Way Out of Despair over Alzheimer’s | OpinionAugust 2021
- Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentAugust 2020
- How Bill Gates Could Transform Alzheimer's DiseaseAugust 2018
- Join now to see all
Press Mentions
Some Trial Volunteers Had Higher Risk of Brain Bleeds. Here’s Why Drugmakers Didn’t Tell ThemJanuary 22nd, 2025
New Clinical Practice Guideline on Process for Diagnosing Alzheimer’s Disease or a Related Form of Cognitive Impairment or DementiaDecember 26th, 2024- New Clinical Practice Guideline on the Process for Diagnosing Alzheimer’s Disease or a Related Form of Cognitive Impairment or DementiaDecember 23rd, 2024
- Join now to see all
Grant Support
- Penn Artificial Intelligence and Technology Collaboratory for Healthy AgingUNIVERSITY OF PENNSYLVANIA2021–2026
- Parkinsons Disease And Research Consent CapacityNational Institute Of Neurological Disorders And Stroke2009–2011
- Core--Education And Information TransferNational Institute On Aging2006–2010
- Consent Methods And Participation In Geriatric Clinical ResearchNational Institute Of Mental Health2007–2009
- Understanding Attitudes About Research Advance PlanningNational Institute Of Mental Health2006
- Improving Informed Consent In Alzheimer Disease ResearchNational Institute On Aging2004–2006
- Core-- Education And Information TransferNational Institute On Aging2001–2002
- Community Equipoise And The Ethics Of Clinical ResearchNational Institute On Aging1998–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
